Holen Sie sich die Stockscreener-App
1.41
1.40%
-0.02
Schlusskurs vom Vortag:
$1.43
Offen:
$1.43
24-Stunden-Volumen:
388.65K
Relative Volume:
0.43
Marktkapitalisierung:
$171.89M
Einnahmen:
$34.16M
Nettoeinkommen (Verlust:
$-50.62M
KGV:
-2.7756
EPS:
-0.508
Netto-Cashflow:
$703.00K
1W Leistung:
-9.03%
1M Leistung:
-22.95%
6M Leistung:
-64.03%
1J Leistung:
-67.95%
1-Tages-Spanne:
$1.36
$1.45
1-Wochen-Bereich:
$1.36
$1.63
52-Wochen-Spanne:
$1.35
$4.96
Omniab Inc Stock (OABI) Company Profile
Firmenname
Omniab Inc
Sektor
Branche
Telefon
510-250-7800
Adresse
5980 HORTON STREET, EMERYVILLE
Vergleichen Sie OABI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OABI
Omniab Inc
|
1.405 | 185.95M | 34.16M | -50.62M | 703.00K | -0.508 |
|
ONC
Beigene Ltd Adr
|
239.03 | 23.78B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.39 | 108.15B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.2548 | 43.44M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
596.50 | 61.69B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
73.08 | 5.72B | 0 | -153.72M | -103.81M | -2.00 |
Omniab Inc Stock (OABI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-11-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-04-21 | Eingeleitet | The Benchmark Company | Buy |
| 2023-04-13 | Eingeleitet | Craig Hallum | Buy |
| 2023-02-22 | Eingeleitet | Cowen | Outperform |
| 2023-02-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-12-20 | Eingeleitet | Truist | Buy |
| 2022-12-16 | Eingeleitet | Credit Suisse | Outperform |
| 2022-11-29 | Eingeleitet | SVB Leerink | Outperform |
| 2022-11-28 | Eingeleitet | Stifel | Buy |
Alle ansehen
Omniab Inc Aktie (OABI) Neueste Nachrichten
OmniAb’s SWOT analysis: antibody discovery firm’s stock faces growth opportunities amid market challenges - Investing.com Canada
OmniAb Inc (NASDAQ: OABI) Could Pass $4 In One Year Stock Forecast - Stocksregister
Insider Spends US$94k Buying More Shares In OmniAb - simplywall.st
Chairman of OmniAb Picks Up 3.0% More Stock - Yahoo Finance
51,159 Shares in OmniAb, Inc. (NASDAQ:OABI) Purchased by Balyasny Asset Management L.P. - Defense World
Price T Rowe Associates Inc. MD Has $136,000 Stock Position in OmniAb, Inc. (NASDAQ:OABI) - Defense World
Leerink Partnrs Has Bullish Forecast for OmniAb Q2 Earnings - Defense World
Insider Buying: Jennifer Cochran Acquires 30,000 Shares of OmniA - GuruFocus
Director Makes Bold Move with Major OmniAb Stock Purchase - TipRanks
Director’s Bold Move: A Major Investment in OmniAb Stock - TipRanks
Insider Buying: John Higgins Acquires 65,000 Shares of OmniAb In - GuruFocus
OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston Summit - marketscreener.com
Hsbc Holdings PLC Makes New Investment in OmniAb, Inc. (NASDAQ:OABI) - Defense World
OmniAb’s (OABI) “Buy” Rating Reaffirmed at Benchmark - Defense World
OmniAb: Too Much Risk, Not Enough Reward (NASDAQ:OABI) - Seeking Alpha
OmniAb, Inc. (NASDAQ:OABI) Q1 2025 Earnings Call Transcript - MSN
OmniAb : May 2025 Corporate Overview - marketscreener.com
Earnings Release: Here's Why Analysts Cut Their OmniAb, Inc. (NASDAQ:OABI) Price Target To US$7.88 - simplywall.st
Dimensional Fund Advisors LP Increases Position in OmniAb, Inc. (NASDAQ:OABI) - Defense World
RBC Capital Remains a Buy on OmniAb (OABI) - The Globe and Mail
OmniAb, Inc. (OABI) Reports Q1 Loss, Misses Revenue Estimates - MSN
OmniAb’s Earnings Call: Growth Amid Challenges - TipRanks
OmniAb Introduces the xPloration® Partner Access Program - BioSpace
OmniAb Q1 2025 slides: Revenue growth and pipeline expansion amid cost controls By Investing.com - Investing.com South Africa
Is OmniAb, Inc. (OABI) the Low Risk High Reward Stock Set to Triple by 2030? - Insider Monkey
OmniAb Introduces the xPloration(R) Partner Access Program - marketscreener.com
OmniAb Reports Steady Growth in Q1 2025 - TipRanks
OmniAb Q1 2025 slides: Revenue growth and pipeline expansion amid cost controls - Investing.com Nigeria
OmniAb, Inc. (NASDAQ:OABI) Shares Acquired by Barclays PLC - Defense World
OmniAb Inc (OABI) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic Partnerships ... By GuruFocus - Investing.com Canada
Wells Fargo & Company MN Purchases 12,278 Shares of OmniAb, Inc. (NASDAQ:OABI) - Defense World
Earnings call transcript: OmniAb’s Q1 2025 shows revenue growth and cost control - Investing.com
10 Low Risk High Reward Stocks Set to Triple by 2030 - Insider Monkey
OmniAb Inc reports results for the quarter ended March 31Earnings Summary - TradingView
OmniAb Reports First Quarter 2025 Financial Results and Business Highlights - Business Wire
OmniAb to Participate in Two Investor Conferences in November - marketscreener.com
Ratio Revelations: OmniAb Inc (OABI)’s Financial Metrics in the Spotlight - DWinneX
Veraxa and OmniAb to develop bispecific ADC tumour programme - Yahoo Finance
OmniAb, Veraxa Biotech Partner on Solid Tumor Drug Discovery Program - marketscreener.com
VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program - The Manila Times
VERAXA Biotech AG and OmniAb, Inc. Announce Co-Discovery Alliance for Novel Bispecific Antibody Drug Conjugate Program Targeting Solid Tumors - Nasdaq
VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program - GlobeNewswire Inc.
VERAXA Biotech Enters Co-Discovery Alliance with OmniAb - Contract Pharma
OmniAb Inc [OABI] Records 200-Day SMA of $3.6405 - knoxdaily.com
A stock that deserves closer examination: OmniAb Inc (OABI) - uspostnews.com
OmniAb to Participate in Five Upcoming Investor Conferences - marketscreener.com
OmniAb Inc (OABI) Stock: Navigating Drops and Gains - investchronicle.com
Legal & General Group Plc Decreases Stock Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World
OmniAb Inc (OABI) can make a big difference with a little luck - Sete News
Ratio Examination: OmniAb Inc (OABI)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX
RBC Capital Mkts initates OmniAb Inc (OABI) stock to an Outperform - knoxdaily.com
Finanzdaten der Omniab Inc-Aktie (OABI)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
8.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):